Abstract
DOPAMINERGIC neuronal pathways arise from mesencephalic nuclei and project axons to the striatum, cortex, limbic system and hypothalamus1,2. Through these pathways dopamine affects many physiological functions, such as the control of coordinated movement and hormone secretion3. Here we have studied the physiological involvement of the dopamine D2 receptors in dopaminergic transmission, using homologous recombination to generate D2-receptor-deficient mice. Absence of D2 receptors leads to animals that are akinetic and bradykinetic in behavioural tests, and which show significantly reduced spontaneous movements. This pheno-type presents analogies with symptoms characteristic of Parkin-son's disease4,5. Our study shows that D2 receptors have a key role in the dopaminergic control of nervous function. These mice have therapeutic potential as a model for investigating and correcting dysfunctions of the dopaminergic system.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Graybiel, A. M., Trends Neurosci. 13, 244–254 (1990).
Alexander, G. A. & Crutcher, M. D. Trends Neurosci. 13, 266–271 (1990).
Jackson, D. M. & Westlind-Danielsson, A. Pharmac. Ther. 64, 291–369 (1994).
Hornykiewicz, O. Pharmac. Rev. 18, 925–964 (1966).
Seeman, P. & Niznik, H. B. FASEB J. 4, 2737–2744 (1990).
Adra, C. N., Boer, P. H. & McBurney, M. W. Gene 60, 65–74 (1987).
Lévesque, D. et al. Proc. natn. Acad. Sci. U.S.A. 89, 8155–8159 (1992).
Zurawski, G. et al. Science 232, 772–775 (1986).
Bannon, M. J. et al. J. biol. Chem. 261, 6640–6642 (1986).
Civelli, O., Douglass, J., Goldstein, A. & Herbert, E. Proc. natn. Acad. Sci. U.S.A. 82, 4291–4295 (1985).
Kaufman, D. L., McGinnis, J. F., Krieger, N. R. & Tobin, A. J. Science 232, 1138–1140 (1986).
Grima, B., Lamouroux, A., Blanot, F., Biguet, N. F. & Mallet, J. Proc. natn. Acad. Sci. U.S.A. 82, 617–621 (1985).
Le Moine, C., Normand, E. & Bloch, B. Proc. natn. Acad. Sci. U.S.A. 88, 4205–4209 (1991).
Kita, H. & Kitai, S. T. Brain Res. 447, 346–352 (1988).
Gerfen, C. R. et al. Science 250, 1429–1432 (1990).
Fuxe, K., Hökfelt, T. & Nilsson, O. Neuroendocrinology 5, 5–15 (1987).
Janssen, P. A. J., Jageneau, A. H. & Schellekens, K. H. L. Psychopharmacologia 1, 389–392 (1960).
Pertwee, R. G. Br. J. Pharmac. 46, 753–763 (1972).
Wolffgramm, J., Rommelspacher, H. & Buck, E. Pharmac. Biochem. Behav. 36, 907–914 (1990).
Xu, M. et al. Cell 79, 729–742 (1994).
Gingrich, J. A. & Caron, M. G. A. Rev. Neurosci. 16, 299–321 (1993).
Drago, J. et al. Proc. natn. Acad. Sci. U.S.A. 91, 12564–12568 (1994).
Meyer, M. E., Cottrell, G. A. & Van Hartesveldt, C. Pharmac. Biochem. Behav. 41, 507–510 (1992).
Morelli, M. & Di Chiara Eur. J. Pharmac. 117, 179–185 (1985).
Ögren, S. O. & Fuxe, K. Neurosci. Lett. 85, 333–338 (1988).
Casey, D. E. Psychopharmacology, 107, 18–22 (1992).
Montmayeur, J.-P. et al. FEBS Lett 278, 239–243 (1991).
Montmayeur, J.-P., Guiramand, J. & Borrelli, E. Molec. Endocr. 7, 161–170 (1993).
Guiramand, J., Montmayeux, J. P., Ceraline, J., Bhatia, M. & Borrelli, E. J. biol. Chem. 270, 7354–7358 (1995).
Dollé, P., Ruberte, E., Leroy, P., Moucis-Kay, G. & Chambon, P. Development 110, 1133–1151 (1990).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Baik, JH., Picetti, R., Saiardi, A. et al. Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature 377, 424–428 (1995). https://doi.org/10.1038/377424a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/377424a0
This article is cited by
-
The molecular pathology of schizophrenia: an overview of existing knowledge and new directions for future research
Molecular Psychiatry (2023)
-
Role of dopamine agonists in Parkinson's disease therapy
Journal of Neural Transmission (2023)
-
Dopaminergic Modulation of Forced Running Performance in Adolescent Rats: Role of Striatal D1 and Extra-striatal D2 Dopamine Receptors
Molecular Neurobiology (2021)
-
G-Protein-Coupled Receptors and Ischemic Stroke: a Focus on Molecular Function and Therapeutic Potential
Molecular Neurobiology (2021)
-
Cocaine-mediated circadian reprogramming in the striatum through dopamine D2R and PPARγ activation
Nature Communications (2020)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.